Evidence mapPaperPMID 42412692Full record

ReviewJACC. Asia2026

Improving Polygenic Risk Prediction for Atherosclerotic Cardiovascular Disease in East Asian Populations.

Junting He, Xuxiang Shen, Minxian Wang, Dongfeng Gu, Xiangfeng Lu

Abstract readReview
In one paragraph

Review in JACC. Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Junting HeDepartment of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xuxiang ShenDepartment of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Minxian WangChina National Center for Bioinformation, Beijing, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China; College of Future Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, China.
Dongfeng GuDepartment of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; School of Public Health and Emergency Management, School of Medicine, Southern University of Science and Technology, Shenzhen, China. Electronic address: gudongfeng@cashq.ac.cn.
Xiangfeng LuDepartment of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: luxf@pumc.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic predisposition contributes substantially to the risk for atherosclerotic cardiovascular disease (ASCVD). Polygenic risk scores (PRS), which quantify this inherited susceptibility, have demonstrated strong predictive performance in European populations, with accumulating evidence supporting their use in clinical practice. However, East Asian populations face a notable gap in PRS development and validation, with limited studies guiding their clinical application. In this state-of-the-art review, the authors summarize current evidence on PRS for coronary artery disease and ischemic stroke, the 2 major subtypes of ASCVD, in East Asian populations. The authors place specific focus on cross-ancestry integration strategies and key methodological considerations to enhance predictive accuracy. Additionally, the authors highlight the clinical utility of ASCVD PRS in primary and secondary prevention and their evaluation in real-world settings and outline strategies for clinical translation into routine care for East Asians. This review underscores the need for initiatives to facilitate the application of PRS across diverse populations.

Indexed as

atherosclerotic cardiovascular diseaseclinical utilitycross-ancestry integrationEast Asianpolygenic risk score

Identifiers

PMID42412692
PMCPMC13350397

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.